Evidence map›Paper›PMID 40659484›Full record

ArticleLife science alliance2025

In vivo detection of antisense HIV-1 transcripts in untreated and ART-treated individuals.

Adam A Capoferri, Rachel Sklutuis, Toluleke O Famuyiwa, Sachi Pathak, Rui Li, Jason W Rausch, Brian T Luke, Rebecca Hoh, Steven G Deeks, John W Mellors and 4 more

Abstract read
In one paragraph

Article in Life science alliance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

  • Update of
    2025
5 · Who and what money

Authors and funding

14 authors.

Adam A CapoferriHIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD, USA adam.capoferri@nih.gov.ORCID 0000-0002-6048-2115
Rachel SklutuisHIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD, USA.
Toluleke O FamuyiwaHIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD, USA.
Sachi PathakHIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD, USA.
Rui LiDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Jason W RauschHIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD, USA.
Brian T LukeAdvanced Biomedical Computational Science, Frederick National Laboratories for Cancer Research, Frederick, MD, USA.
Rebecca HohDepartment of Medicine, University of California, San Francisco, CA, USA.
Steven G DeeksDepartment of Medicine, University of California, San Francisco, CA, USA.
John W MellorsDivision of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
John M CoffinDepartment of Molecular Biology and Microbiology, Tufts University, Boston, MA, USA.ORCID 0000-0003-3856-762X
Jennifer L GroebnerHIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD, USA.ORCID 0000-0003-1503-5030
Fabio RomerioDepartment of Molecular and Comparative Pathobiology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.ORCID 0000-0002-2070-297X
Mary F KearneyHIV Dynamics and Replication Program, National Cancer Institute, Frederick, MD, USA kearneym@nih.gov.ORCID 0000-0003-3839-6576

Funding

Structural Biology CoreU54AI170855 · NIAID · SEATTLE CHILDREN'S HOSPITAL · PI Stefan G Sarafianos, Bruce Edward Torbett · 2022 to 2026
$36.7M
Effects of Antiretroviral Therapy on Transcriptional Activity of HIV ProvirusesZIABC011697 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KEARNEY, MARY · 2016 to 2024
$6.4M
Sustained HIV Remission via Sequence-Specific Epigenetic Silencing of Latent ProvirusesR01AI144983 · NIAID · UNIVERSITY OF MARYLAND BALTIMORE · PI ROMERIO, FABIO · 2019 to 2024
$3.6M
Human endogenous provirus inhibition of HIV replicationR01AI184043 · NIAID · TUFTS UNIVERSITY BOSTON · PI JOHN M COFFIN · 2024 to 2026
$2.1M
PHASE I THERAPEUTIC AWARD: CHIMERIC NANOPARTICLE DELIVERY OF AN SARNA-BASED CANCER VACCINE FOR FAMILIAL ADENOMATOUS POLYPOSIS75N91024C00011 · NCI · CHIMERON BIO CORPORATION · PI SIMMONS, ALFRED · 2024 to 2024
$300k
Intramural AIDS Research Fellowship (AA Capoferri) from the Office of AIDS ResearchIntramural NIH HHS ZIA BC011697NCI NIH HHS 75N91024C00011NIAID NIH HHS R01 AI144983NIAID NIH HHS R01 AI184043NIAID NIH HHS U54 AI170855
6 · The paper itself

Abstract

Natural antisense transcripts (AST) are expressed in eukaryotes, prokaryotes, and viruses and can possess regulatory functions at the transcriptional and/or post-transcriptional levels. In vitro studies have shown that HIV-1 AST promote viral latency through epigenetic silencing of the proviral 5' long terminal repeat. However, expression of AST in vivo has not been convincingly demonstrated. Here, we used single RNA template amplification and sequencing to demonstrate expression of AST in unstimulated PBMC collected from people with HIV-1 (PWH). Our results show that expression levels of AST could be higher during ART compared with untreated individuals and that clones of infected cells persisting under ART continue to express HIV AST. This study is the first to verify HIV-1 AST expression in vivo with sequencing, documenting AST presence without cellular activation and suggest its natural occurrence in PWH. These findings advance our understanding of HIV-1 persistence and underscore the need for larger studies to determine if targeting AST in viral reservoirs could lead to new approaches for the design of strategies towards achieving HIV remission without ART.

Indexed as

HIV-1HIV InfectionsRNA, AntisenseAdultFemaleGene Expression Regulation, ViralHumansLeukocytes, MononuclearMaleMiddle AgedRNA, ViralVirus LatencyRNA, AntisenseRNA, Viral

Identifiers

PMID40659484
PMCPMC12260654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.